Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Impact of Covid-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt From Challenges and Countermeasures of Major Asian Cancer Centres Publisher Pubmed



Gatellier L1 ; Shankar A2 ; Dewi LKM3 ; Hussain QM4 ; Wangdi TD5 ; Sukumaran DB6 ; Sari NK3 ; Shiraji ST7 ; Biglari M7 ; Tahmasebi M8 ; Iwata S1 ; Suzuki T1 ; Myung SK9 ; Chun JY9 Show All Authors
Authors
  1. Gatellier L1
  2. Shankar A2
  3. Dewi LKM3
  4. Hussain QM4
  5. Wangdi TD5
  6. Sukumaran DB6
  7. Sari NK3
  8. Shiraji ST7
  9. Biglari M7
  10. Tahmasebi M8
  11. Iwata S1
  12. Suzuki T1
  13. Myung SK9
  14. Chun JY9
  15. Han JS9
  16. Lau FN10
  17. Yusak S10
  18. Bayarsaikhan L11
  19. Mu KT12
  20. Pradhananga KK13
  21. Yusuf A14
  22. Lin CH15
  23. Chiang RCJ16
  24. Sangrajran S17
  25. Nguyen QT18
  26. Huong GN18
  27. Soe AN19
  28. Sharma DN20
  29. Sengar M21
  30. Pramesh CS21
  31. Matsuda T1
  32. Jarrahi AM22
  33. Hwang W23
Show Affiliations
Authors Affiliations
  1. 1. National Cancer Center, Tokyo, Japan
  2. 2. Lady Hardinge Medical College & Associated Hospitals, Delhi, India
  3. 3. Dharmais Hospital, National Cancer Center, Jakarta, Indonesia
  4. 4. National Institute of Cancer Research and Hospital, Dhaka, Bangladesh
  5. 5. JDWNR Hospital Thimphu University of Medical Sciences, Bhutan
  6. 6. The Brunei Cancer Centre, Brunei Darussalam
  7. 7. Hematology, Oncology and Bone Marrow transplantation Research Center, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran
  8. 8. Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. National Cancer Center of Korea, Goyang-si, Gyeonggi-do, South Korea
  10. 10. National Cancer Institute, Putrajaya, Malaysia
  11. 11. National Cancer Center of Mongolia, Ulaanbaatar, Mongolia
  12. 12. Myanmar Yangon General Hospital, Yangon, Myanmar
  13. 13. Kathmandu Cancer Center, Bhaktapur, Nepal
  14. 14. Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan
  15. 15. National Taiwan University Cancer Center Hospital, Taipei City, Taiwan
  16. 16. Taiwan Cancer Registry, and Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
  17. 17. National Cancer Institute, Bangkok, Thailand
  18. 18. National Cancer Institute, National Cancer Hospital, Hanoi, Viet Nam
  19. 19. City Cancer Challenge Foundation, Geneva, Switzerland
  20. 20. Dr BR Ambedkar Institute Rotary Cancer Hospital & National Cancer Institute, All India Institute of Medical Sciences, Delhi, India
  21. 21. Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
  22. 22. Medical School, Shahid Behshti University of Medical Sciences, Tehran, Iran
  23. 23. National Cancer Centre, Singapore

Source: Asian Pacific Journal of Cancer Prevention Published:2021


Abstract

Objective: The COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid and long-term impact of COVID-19 to cancer care in Asia. Methods: The two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures. Results: Participating stakeholders distilled five big questions. 1) “Will there be an explosion of late-stage cancers after the pandemic?” To address and recover from perceived delayed prevention, screening, treatment and care challenges, collaboration of key stakeholders in the region and alignment in cancer care management, policy intervention and cancer registry initiatives would be of essential value. 2) “Operations and Finance” The pandemic has resulted in significant material and financial casualties. Flagged acute challenges (shortages of supplies, imposition of lockdown) as well as longer-standing reduction of financial revenue, manpower, international collaboration, and training should also be addressed. 3) “Will telemedicine and technological innovations revolutionize cancer care?” Deploying and implementing telemedicine such as teleconsultation and virtual tumour boards were considered invaluable. These innovations could become a new regular practice, leading to expansion of tele-collaboration through collaboration of institutions in the region. 4) “Will virtual conferences continue after the pandemic?” Virtual conferences during the pandemic have opened new doors for knowledge sharing, especially for representatives of low and middle-income countries in the region, while saving time and costs of travel. 5) “How do we prepare for the next pandemic or international emergency?” Roadmaps for action to improve access to appropriate patient care and research were identified and scrutinised. Conclusion: Through addressing these five big questions, focused collaboration among members and with international organisations such as City Cancer Challenge will allow enhanced preparedness for future international emergencies. © This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License.